Vose JM - Search Results

1

Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis.

Evens AM, Advani R, Press OW, Lossos IS, Vose JM, Hernandez-Ilizaliturri FJ, Robinson BK, Otis S, Nadav Dagan L, Abdallah R, Kroll-Desrosiers A, Yarber JL, Sandoval J, Foyil K, Parker LM, Gordon LI, Blum KA, Flowers CR, Leonard JP, Habermann TM, Bartlett NL. Evens AM, et al. Among authors: vose jm. J Clin Oncol. 2013 Nov 10;31(32):4132-9. doi: 10.1200/JCO.2013.49.8220. Epub 2013 Sep 16. J Clin Oncol. 2013. PMID: 24043736

2

Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.

Coiffier B, Gisselbrecht C, Vose JM, Tilly H, Herbrecht R, Bosly A, Armitage JO. Coiffier B, et al. Among authors: vose jm. J Clin Oncol. 1991 Feb;9(2):211-9. doi: 10.1200/JCO.1991.9.2.211. J Clin Oncol. 1991. PMID: 1703226

3

Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma.

Bashir RM, Bierman PJ, Vose JM, Weisenburger DD, Armitage JO. Bashir RM, et al. Among authors: vose jm. Am J Clin Oncol. 1991 Dec;14(6):478-82. doi: 10.1097/00000421-199112000-00004. Am J Clin Oncol. 1991. PMID: 1720278

4

Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease.

Armitage JO, Bierman PJ, Vose JM, Anderson JR, Weisenburger DD, Kessinger A, Reed EC, Vaughan WP, Coccia PF, Purtilo DT. Armitage JO, et al. Among authors: vose jm. Am J Med. 1991 Dec;91(6):605-11. doi: 10.1016/0002-9343(91)90213-h. Am J Med. 1991. PMID: 1750430

5

Diffuse "histiocytic" lymphoma.

Vose JM, Armitage JO. Vose JM, et al. Semin Oncol. 1991 Feb;18(1):50-60. Semin Oncol. 1991. PMID: 1992524 Review. No abstract available.

6

The present status of therapy for patients with aggressive non-Hodgkin's lymphoma.

Vose JM, Armitage JO. Vose JM, et al. Ann Oncol. 1991 Feb;2 Suppl 2:171-6. doi: 10.1007/978-1-4899-7305-4_27. Ann Oncol. 1991. PMID: 2049315 Free article. Review.

7

CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity.

Vose JM, Bierman PJ, Anderson JR, Weisenburger D, Moravec DF, Sorensen S, Hutchins M, Dowling MD, Howe D, Okerbloom J, et al. Vose JM, et al. J Clin Oncol. 1991 Aug;9(8):1421-5. doi: 10.1200/JCO.1991.9.8.1421. J Clin Oncol. 1991. PMID: 2072145

8

Salvage therapy for patients with non-Hodgkin's lymphoma.

Armitage JO, Vose JM, Bierman PJ. Armitage JO, et al. Among authors: vose jm. J Natl Cancer Inst Monogr. 1990;(10):39-43. J Natl Cancer Inst Monogr. 1990. PMID: 2189475 Review.

9

The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.

Vose JM, Armitage JO, Weisenburger DD, Bierman PJ, Sorensen S, Hutchins M, Moravec DF, Howe D, Dowling MD, Mailliard J, et al. Vose JM, et al. J Clin Oncol. 1988 Dec;6(12):1838-44. doi: 10.1200/JCO.1988.6.12.1838. J Clin Oncol. 1988. PMID: 2462026

10

Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma.

Armitage JO, Vose JM, Linder J, Weisenburger D, Harrington D, Casey J, Bierman P, Sorensen S, Hutchins M, Moravec DF, et al. Armitage JO, et al. Among authors: vose jm. J Clin Oncol. 1989 Dec;7(12):1783-90. doi: 10.1200/JCO.1989.7.12.1783. J Clin Oncol. 1989. PMID: 2585020

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

517 results

Search Page